Apalutamide (APA) and overall survival (OS) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Updated results from the phase III SPARTAN study

Matthew R. Smith, Fred Saad, S. Chowdhury, Stéphane Oudard, Boris Hadaschik, Julie N. Graff, David Olmos, Paul N. Mainwaring, J.Y. Lee, Hiroji Uemura,

Annals of Oncology · 2019 · 14 citations · 0 references

DOIFull text

Open access

Concepts